15496 Federal Register / Vol. 74, No. 64 / Monday, April 6, 2009 / Notices 

The agenda for this meeting is being 

developed. The agenda will be posted 

on the CFSAC Web site, http:// 

www.hhs.gov/advcomcfs, when it is 

finalized. 

Public attendance at the meeting is 

limited to space available. Individuals 

must provide a photo ID for entry into 

the building where the meeting is 

scheduled to be held. Individuals who 

plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

designated contact person. Members of 

the public will have the opportunity to 

provide comments at the meeting. 

Individuals who wish to address the 

Committee during the public comment 

session must pre-register by May 22, 

2009. Any individual who wishes to 

participate in the public comment 

session should call the telephone 

number listed in the contact information 

to register. Public comment will be 

limited to five minutes per speaker. 

Members of the public who wish to 

have printed material distributed to 

CFSAC members for discussion should 

submit, at a minimum, one copy of the 

materials to the Executive Secretary 

CFSAC, prior to close of business on 

May 22, 2009. Contact information for 

the Executive Secretary, CFSAC is listed 

above. 

Dated: March 24, 2009. 

Wanda K. Jones, 

Deputy Assistant Secretary for Health, 

(Women’s Health) and Executive Secretary 

CFSAC. 

[FR Doc. E9–7549 Filed 4–3–09; 8:45 am] 

BILLING CODE 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Biodefense 

Science Board 

AGENCY: Department of Health and 

Human Services, Office of the Secretary. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Services is hereby giving notice that the 

National Biodefense Science Board 

(NBSB) will be holding a public 

meeting. The meeting is open to the 

public. 

DATES: The NBSB will hold a public 

meeting on April 22, 2009 from 1 p.m. 

to 5 p.m. EDT and on April 23, 2009 

from 8:30 a.m. to 12:15 p.m. This 

agenda is subject to change as priorities 

dictate. 

ADDRESSES: Hyatt Regency Crystal City, 

2799 Jefferson Davis Highway, 

Arlington, VA 22202; Phone: 703–418– 

1234. 

FOR FURTHER INFORMATION CONTACT: 

CAPT Leigh A. Sawyer, D.V.M., M.P.H., 

Executive Director, National Biodefense 

Science Board, Office of the Assistant 

Secretary for Preparedness and 

Response, U.S. Department of Health 

and Human Services, 330 C Street, SW., 

Switzer Building Room 5127, 

Washington, DC 20447; 202–205–3815; 

fax: 202–205–8508; e-mail address: 

leigh.sawyer@hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to section 319M of the Public Health 

Service Act (42 U.S.C. 247d–7f) and 

section 222 of the Public Health Service 

Act (42 U.S.C. 217a), the Department of 

Health and Human Services established 

the National Biodefense Science Board. 

The Board shall provide expert advice 

and guidance to the Secretary on 

scientific, technical, and other matters 

of special interest to the Department of 

Health and Human Services regarding 

current and future chemical, biological, 

nuclear, and radiological agents, 

whether naturally occurring, accidental, 

or deliberate. The Board may also 

provide advice and guidance to the 

Secretary on other matters related to 

public health emergency preparedness 

and response. 

The tentative agenda includes a 

briefing by the National Biosurveillance 

Advisory Subcommittee (NBAS) on 

Enhancing Nationwide Biosurveillance 

for Human Health; a briefing by the 

Office of the National Coordinator on 

Health Information Technology; and a 

presentation by the National 

Commission on Children and Disasters. 

The NBSB will receive updates from the 

Pandemic Influenza Working Group, the 

Disaster Medicine Working Group, the 

Markets and Sustainability Working 

Group, the Personal Preparedness 

Working Group, and the Disaster Mental 

Health Subcommittee. Additional topics 

will be considered during the public 

meeting. This agenda is subject to 

change as priorities dictate. 

Availability of Materials: The draft 

agenda and other materials will be 

posted on the NBSB Web site at 

http://www.hhs.gov/aspr/omsph/nbsb 

prior to the meeting. This agenda is 

subject to change as priorities dictate. 

Procedures for Providing Public Input: 

Any member of the public providing 

oral comments at the meeting must signin at the registration desk and provide 

his/her name, address, and affiliation. 

Members of the public may also file 

written comments with the committee. 

All written comments must be received 

prior to April 15, 2009 and should be 

sent by e-mail to NBSB@hhs.gov with 

‘‘NBSB Public Comment’’ as the subject 

line or mailed to Leigh Sawyer, 330 C 

Street, SW., Switzer Building Room 

5127, Washington, DC 20447. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the designated contact person. 

The Public Meeting Conference Call 

Number is (866) 395–4129. The 

Conference ID is ASPR. Participants will 

be asked to provide their name, title, 

and organization. 

Dated: March 30, 2009. 

RADM William C. Vanderwagen, 

Assistant Secretary for Preparedness and 

Response, U.S. Department of Health and 

Human Services. 

[FR Doc. E9–7550 Filed 4–3–09; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0652] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Notice of 

Participation 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by May 6, 

2009. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–6974, or e-mailed to 

oira_submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–0191. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management (HFA–710), Food and Drug 


pwalker on PROD1PC71 with NOTICES